Time to reality check the promises of machine learning-powered precision medicine
Tài liệu tham khảo
Macklon, 2019, Building an evidence base for IVF ‘add-ons’, Reprod Biomed Online, 38, 853, 10.1016/j.rbmo.2019.04.005
Matheny, 2019, Artificial intelligence in health care: a report from the National Academy of Medicine, JAMA, 323, 509, 10.1001/jama.2019.21579
Gombar, 2019, It is time to learn from patients like mine, NPJ Digit Med, 2, 16, 10.1038/s41746-019-0091-3
2019, Next generation public health: towards precision and fairness, Lancet Public Health, 4, e209, 10.1016/S2468-2667(19)30064-7
Bien, 2018, Deep-learning-assisted diagnosis for knee magnetic resonance imaging: development and retrospective validation of MRNet, PLoS Med, 15, 10.1371/journal.pmed.1002699
Hannun, 2019, Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network, Nat Med, 25, 65, 10.1038/s41591-018-0268-3
Rajpurkar, 2018, Deep learning for chest radiograph diagnosis: a retrospective comparison of the CheXNeXt algorithm to practicing radiologists, PLoS Med, 15, 10.1371/journal.pmed.1002686
Vollmer, 2020, Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness, BMJ, 368
Davis
Gallagher
Liu, 2019, A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis, Lancet Digital Health, 1, e271, 10.1016/S2589-7500(19)30123-2
van Smeden, 2018, Machine learning compared with pathologist assessment, JAMA, 319, 1725, 10.1001/jama.2018.1466
Nagendran, 2020, Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies, BMJ, 368, m689, 10.1136/bmj.m689
Volkmann, 2019, A plea for taking all available clinical information into account when assessing the predictive value of omics data, BMC Med Res Methodol, 19, 162, 10.1186/s12874-019-0802-0
Abràmoff, 2018, Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices, NPJ Digit Med, 1, 39, 10.1038/s41746-018-0040-6
Damen, 2016, Prediction models for cardiovascular disease risk in the general population: systematic review, BMJ, 353
Beede
Zhang, 2019, Learning for personalized medicine: a comprehensive review from a deep learning perspective, IEEE Rev Biomed Eng, 12, 194, 10.1109/RBME.2018.2864254
Hernán, 2020
Peters, 2017
Greenland, 1999, Causal diagrams for epidemiologic research, Epidemiology, 10, 37, 10.1097/00001648-199901000-00008
Angrist, 2009
Rothman, 2013, Why representativeness should be avoided, Int J Epidemiol, 42, 1012, 10.1093/ije/dys223
Shmueli, 2010, To explain or to predict?, Statist Sci, 25, 289, 10.1214/10-STS330
Hernán, 2019, A second chance to get causal inference right: a classification of data science tasks, Chance, 32, 42, 10.1080/09332480.2019.1579578
Arnold, 2020, Reflections on modern methods: generalized linear models for prognosis and intervention—theory, practice and implications for machine learning, Int J Epidemiol
Senn, 2016, Mastering variation: variance components and personalised medicine, Stat Med, 35, 966, 10.1002/sim.6739
Pearson, 2006, Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations, N Engl J Med, 355, 467, 10.1056/NEJMoa061759
Sundström, 2019, The Precision HYpertenSIon Care (PHYSIC) study: a double-blind, randomized, repeated cross-over study, Ups J Med Sci, 124, 51, 10.1080/03009734.2018.1498958
Peto, 2011, Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care, Br J Cancer, 104, 1057, 10.1038/bjc.2011.79
Kent, 2018, Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects, BMJ, 363
van Klaveren, 2019, Models with interactions overestimated heterogeneity of treatment effects and were prone to treatment mistargeting, J Clin Epidemiol, 114, 72, 10.1016/j.jclinepi.2019.05.029
Antoniou, 2017, Biomarker-guided non-adaptive trial designs in phase 2 and phase 3: a methodological review, J Pers Med, 7, 1, 10.3390/jpm7010001
Burke, 2015, Three simple rules to ensure reasonably credible subgroup analyses, BMJ, 351